419 related articles for article (PubMed ID: 16099624)
41. Failure of a 5-day course of intramuscular ceftriaxone to eradicate Streptococcus pneumoniae from the middle ear.
Anon JB; Ripple WL; Jacobs MR
Pediatr Infect Dis J; 2006 Feb; 25(2):181-2. PubMed ID: 16462302
[TBL] [Abstract][Full Text] [Related]
42. Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone.
Böttcher T; Ren H; Goiny M; Gerber J; Lykkesfeldt J; Kuhnt U; Lotz M; Bunkowski S; Werner C; Schau I; Spreer A; Christen S; Nau R
J Neurochem; 2004 Dec; 91(6):1450-60. PubMed ID: 15584921
[TBL] [Abstract][Full Text] [Related]
43. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
[TBL] [Abstract][Full Text] [Related]
44. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.
Fitoussi F; Doit C; Benali K; Bonacorsi S; Geslin P; Bingen E
Antimicrob Agents Chemother; 1998 Apr; 42(4):942-4. PubMed ID: 9559815
[TBL] [Abstract][Full Text] [Related]
45. Successful antibiotic eradication of Streptococcus pneumoniae infection of a ventriculoatrial shunt.
Orvin K; Bilavsky E; Weiner E; Shouval DS; Amir J
Int J Infect Dis; 2009 May; 13(3):e101-3. PubMed ID: 18948047
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of community acquired bacterial meningitis, after microbiological identification].
Stahl JP
Med Mal Infect; 2009; 39(7-8):513-20. PubMed ID: 19394177
[TBL] [Abstract][Full Text] [Related]
47. Emergence of rifampin-resistant Streptococcus pneumoniae as a result of antimicrobial therapy for penicillin-resistant strains.
van Tilburg PM; Bogaert D; Sluijter M; Jansz AR; de Groot R; Hermans PW
Clin Infect Dis; 2001 Oct; 33(8):e93-6. PubMed ID: 11550121
[TBL] [Abstract][Full Text] [Related]
48. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
Bañón Arias R; García López M; Pinedo Sánchez A
J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
[TBL] [Abstract][Full Text] [Related]
49. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis.
Buckingham SC; McCullers JA; Luján-Zilbermann J; Knapp KM; Orman KL; English BK
Pediatrics; 2006 May; 117(5):1688-94. PubMed ID: 16651325
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.
Stucki A; Gerber P; Acosta F; Cottagnoud M; Cottagnoud P
Antimicrob Agents Chemother; 2006 Feb; 50(2):770-3. PubMed ID: 16436742
[TBL] [Abstract][Full Text] [Related]
51. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
[TBL] [Abstract][Full Text] [Related]
52. Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
París MM; Shelton S; Trujillo M; Hickey SM; McCracken GH
Antimicrob Agents Chemother; 1996 Jan; 40(1):122-6. PubMed ID: 8787892
[TBL] [Abstract][Full Text] [Related]
53. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.
Cabellos C; Martinez-Lacasa J; Martos A; Tubau F; Fernández A; Viladrich PF; Gudiol F
Antimicrob Agents Chemother; 1995 Sep; 39(9):2158-60. PubMed ID: 8540738
[TBL] [Abstract][Full Text] [Related]
54. Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
McCracken GH
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S45-50. PubMed ID: 10984328
[TBL] [Abstract][Full Text] [Related]
55. [Meningitis due to cefotaxime-resistant Streptococcus pneumoniae].
Martín Fontelos P; Barreiro Casal G; Villota Arrieta J; Pérez Jurado ML; García López M; Mellado Peña MJ; Cilleruelo Ortega MJ
An Esp Pediatr; 1996 Apr; 44(4):395-6. PubMed ID: 8796948
[No Abstract] [Full Text] [Related]
56. Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae isolates in Taiwan.
Chiu CH; Su LH; Huang YC; Lai JC; Chen HL; Wu TL; Lin TY
Antimicrob Agents Chemother; 2007 Sep; 51(9):3404-6. PubMed ID: 17591850
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
McCracken GH; Sakata Y
Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
[TBL] [Abstract][Full Text] [Related]
58. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
John CC
Clin Infect Dis; 1994 Feb; 18(2):188-93. PubMed ID: 8161625
[TBL] [Abstract][Full Text] [Related]
59. Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.
Vivas M; Force E; Garrigós C; Tubau F; Platteel AC; Ariza J; Cabellos C
J Antimicrob Chemother; 2014 Nov; 69(11):3020-6. PubMed ID: 24962033
[TBL] [Abstract][Full Text] [Related]
60. Penicillin-resistant pneumococcal meningitis in Israel.
Steinberg T; Rachmel A; Samra Z; Ashkenazi S
Isr J Med Sci; 1997 Nov; 33(11):757-9. PubMed ID: 9434816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
